UNSPSC 51342310: Valacyclovir hydrochloride

This classification denotes a purine antagonist and antiviral agent with the molecular formula C13H20N6O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G447S0T1VC, chemically known as l-valine, ester with 9-((2-hydroxyethoxy)methyl)guanine, monohydrochloride but generally known as valaciclovir hydrochloride, which bears US NIH Compound Identifier 60772. European Medicines Agency schedules Valaciclovir hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15679MIG.

As of Q4 2014, VALACYCLOVIR HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Valacyclovir hydrochloride bears US NLM identifiers UMLS ID C0771309 and NCI Concept Code C29535. SMILES: CL.O(C(=O)C(N)C(C)C)CCOCN1C2[NH]C(NC(=O)C2NC1)N.

UNSPSC 51342310 Valacyclovir hydrochloride is a Commodity code representing a specific antiviral pharmaceutical product. Recent state and local solicitations tagged under this code do not reflect purchases of valacyclovir hydrochloride itself; instead, the tagged opportunities involve procurement of other pharmaceuticals and medical supplies including doxycycline hyclate, ciprofloxacin hydrochloride, naloxone, and drug deactivation systems. The mismatch suggests that the code's classification may not align with current purchasing patterns, or that state and local procurement offices are applying the code inconsistently to related pharmaceutical and medical supply categories rather than to valacyclovir hydrochloride alone.

The recent opportunities show issuing bodies ranging from state health departments to county governments. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate and ciprofloxacin hydrochloride tablets totaling $2,999,999.11 over a three-year contract term via an Invitation for Bid process. Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through an IFB posted June 30, 2026, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Activity spans Florida and Illinois with likely broader geographic application given the use of cooperative purchasing vehicles such as MMCAP Infuse, which enables multiple jurisdictions to piggyback on awarded contracts. Without recent opportunities directly matching valacyclovir hydrochloride procurement, the code shows limited decision-relevant activity for vendors focused on that specific product line.